Positive and negative symptom scale(PANSS)and treatment emergent symptom scale(TESS)were used to assess the efficacy and side effects before and after treatments at the end of 4th,8th,12th week.

• 使用阳性与阴性症状量表(PANSS)和治疗中出现的症状量表(TESS),在治疗前和治疗4、8、12周末各评定1次。结果:联用西酞普兰12周后,PANSS总分、阴性症状因子分及情感迟钝、情感退缩、情感交流障碍、被动/淡漠及社交退缩分均比治疗前显著降低。